Sutro Biopharma Inc. logo

Sutro Biopharma Inc.

STRO | NASDAQ
Chart Builder DCF Calculator
$16.31
-$0.04 (-0.24%)
Sep 22, 2026, 12:30 PM ET · Market open
Fiscal Year
Period Ending
FY 2025
Dec 30, 2025
FY 2024
Dec 30, 2024
FY 2023
Dec 30, 2023
FY 2022
Dec 30, 2022
FY 2021
Dec 30, 2021
FY 2020
Dec 30, 2020
Net Income
-191.09M -227.46M -106.79M -119.2M -105.54M -32.13M
Depreciation & Amortization
7.32M 7.22M 6.82M 5.69M 4.84M 4.3M
Stock-Based Compensation
14.01M 24.69M 24.91M 26.3M 23.24M 11.92M
Other Working Capital
-52.57M -19.27M -10.23M 100.29M -12.61M -11.22M
Other Non-Cash Items
42.92M -4.88M -2.17M -13.65M 6.16M 606K
Deferred Income Tax
n/a n/a n/a n/a 7.24M -41.01M
Change in Working Capital
-50.4M 8.9M -34.38M 104.41M -17.62M -11.49M
Operating Cash Flow
-177.23M -191.54M -111.62M 3.55M -81.68M -67.8M
Capital Expenditures
-1.7M -3.1M -4.32M -7.86M -15.32M -7.13M
Cash Acquisitions
n/a n/a n/a 28.74M n/a n/a
Purchase of Investments
-264.95M -461.52M -460.3M -216.67M -248.73M -130.74M
Sales Maturities Of Investments
311.66M 683.13M 460.69M 189.5M 166.73M 138.39M
Other Investing Acitivies
n/a n/a n/a -28.73M 9K 89K
Investing Cash Flow
45.01M 218.51M -3.92M -35.02M -97.32M 604K
Debt Repayment
n/a -4.08M -12.5M -9.38M n/a 15M
Common Stock Repurchased
n/a n/a n/a n/a -7K n/a
Dividend Paid
n/a n/a n/a n/a n/a n/a
Other Financial Acitivies
-332K 1.61M 138.08M 1.42M 4.25M 2.83M
Financial Cash Flow
44K 94.05M 137.55M 48.31M 3.26M 269.25M
Net Cash Flow
-132.17M 121.02M 22.01M 16.84M -175.74M 202.05M
Free Cash Flow
-178.93M -194.64M -115.93M -4.31M -97M -74.93M
Adj. Free Cash Flow
-192.93M -219.33M -140.84M -30.61M -120.24M -86.85M
Maintenance CapEx
n/a -3.1M n/a -5.13M -7.73M -7.13M
Growth CapEx
-1.7M n/a -4.32M -2.73M -7.59M n/a
Owner Earnings
-177.23M -194.64M -111.62M -1.58M -89.41M -74.93M

© 2026 bestshares.com. All rights reserved.